panic disorder/мачнина

Врската е зачувана во таблата со исечоци

Изберете вид на сортирање

Страница 1 од 78 резултати

Low-dose mirtazapine added to selective serotonin reuptake inhibitors in pregnant women with major depression or panic disorder including symptoms of severe nausea, insomnia and decreased appetite: three cases.

Само регистрираните корисници можат да преведуваат статии

Пријавете се / пријавете се

Data on the use of a combination of antidepressants during pregnancy are inadequate. This report presents the beneficial effect of low-dose mirtazapine added onto selective serotonin reuptake inhibitors in the treatment of the symptoms of severe nausea, insomnia and loss of appetite accompanying

The symptom structure of panic disorder: a trial using factor and cluster analysis.

Само регистрираните корисници можат да преведуваат статии

Пријавете се / пријавете се

Using cluster analysis of 207 patients with panic disorder (PD), we investigated the relationships between several panic symptoms at the time of panic attacks, which included anticipatory anxiety, agoraphobia, and 13 clinical symptoms based on the Diagnostic and Statistics Manual-III-Revised.

Moclobemide for anxiety disorders: a focus on moclobemide for panic disorder.

Само регистрираните корисници можат да преведуваат статии

Пријавете се / пријавете се

Moclobemide is a reversible selective inhibitor of monoamine oxidase A. It has proven efficacy in a wide range of depressive disorders, including agitated anxious depression. In an international, multicentre, double-blind parallel-group study, the tolerability and efficacy of moclobemide were

Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo.

Само регистрираните корисници можат да преведуваат статии

Пријавете се / пријавете се

Side effects play a significant role in the selection of drugs to be used in panic disorder/agoraphobia whose polyphobic symptomatology often includes a suspiciousness about taking drugs and a fear of undesired side effects which may lead to the refusal of treatment. The safety, side effects and

A double-blind comparative study of brofaromine and fluvoxamine in outpatients with panic disorder.

Само регистрираните корисници можат да преведуваат статии

Пријавете се / пријавете се

Previous studies have shown that both selective serotonin reuptake inhibitors (SSRIs) and monoamine oxidase inhibitors (MAOIs) are effective in the treatment of panic disorders (PD). In this study, the SSRI fluvoxamine (Fluv) was compared with the MAO-A-I brofaromine (Brof). Thirty patients with the

Behavioral, neuroendocrine and biochemical effects of different doses of 5-HTP in panic disorder.

Само регистрираните корисници можат да преведуваат статии

Пријавете се / пријавете се

To investigate the role of serotonin (5-HT) in the pathophysiology of panic disorder (PD) a challenge test with L-5-hydroxytryptophan (5-HTP) was conducted. Seven patients suffering from PD and seven healthy controls received an i.v. challenge with 10 mg, 20 mg and 40 mg 5-HTP and placebo in random

Duloxetine in panic disorder with somatic gastric pain.

Само регистрираните корисници можат да преведуваат статии

Пријавете се / пријавете се

PANIC DISORDER IS THE MOST COMMON TYPE OF ANXIETY DISORDER, AND ITS MOST COMMON EXPRESSION IS PANIC ATTACKS CHARACTERIZED WITH SUDDEN ATTACKS OF ANXIETY WITH NUMEROUS SYMPTOMS, INCLUDING PALPITATIONS, TACHYCARDIA, TACHYPNEA, NAUSEA, AND VERTIGO: ie, cardiovascular, gastroenterologic, respiratory,

Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.

Само регистрираните корисници можат да преведуваат статии

Пријавете се / пријавете се

CONCLUSIONS Paroxetine is the first selective serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitor (SSRI) to be approved for the treatment of patients with panic disorder with or without agoraphobia. It is a highly selective inhibitor of presynaptic serotonin reuptake and does not interact with

The efficacy and safety of moclobemide compared to clomipramine in the treatment of panic disorder.

Само регистрираните корисници можат да преведуваат статии

Пријавете се / пријавете се

The primary objectives of this multicenter study were to determine the efficacy and safety of moclobemide, a selective reversible inhibitor of monoamino oxidase A, as drug treatment in DSM-III-R panic disorder with and without agoraphobia. In a comparative double-blind, randomized parallel-group

Current concepts in the treatment of panic disorder.

Само регистрираните корисници можат да преведуваат статии

Пријавете се / пријавете се

Panic disorder is a prevalent psychiatric condition that often is chronic and rarely resolves without medical intervention. Many patients with panic disorder initially present with a variety of somatic symptoms, including chest pain, nausea, or dizziness, and patients frequently seek care in

Mirtazapine versus fluoxetine in the treatment of panic disorder.

Само регистрираните корисници можат да преведуваат статии

Пријавете се / пријавете се

Mirtazapine is an antidepressant whose side effect profile differs from that of first-line agents (selective serotonin reuptake inhibitors) used in the treatment of panic disorder. The present study compared the effect of mirtazapine and fluoxetine in the treatment of panic disorder in a

MAO inhibitors in panic disorder: clinical effects of treatment with brofaromine. A double blind placebo controlled study.

Само регистрираните корисници можат да преведуваат статии

Пријавете се / пријавете се

There is considerable evidence that antidepressants, particularly serotonin uptake inhibitors, are effective in the treatment of panic disorder (PD). Monoamine oxidase inhibitors (MAOI) may also have beneficial effects in PD. In this study 30 patients with PD with or without agoraphobia (DSM-III-R)

Panic disorder.

Само регистрираните корисници можат да преведуваат статии

Пријавете се / пријавете се

Panic disorder is a chronic illness that affects at least 3 percent of the population. Panic disorder is associated with significant morbidity and an increased risk of suicide. Patients generally present with multiple somatic and psychologic complaints, including heart palpitations, chest pain,

Paroxetine in panic disorder: clinical management and long-term follow-up.

Само регистрираните корисници можат да преведуваат статии

Пријавете се / пријавете се

Panic disorder is one of the most common anxiety disorders and has a lifetime prevalence of 3-5%. Panic attacks can begin at any age, but commonly have their onset in early adulthood between the ages of 20 and 40 years. Naturalistic data has shown that panic disorder has a chronic and relapsing

Selective serotonin reuptake inhibitors and benzodiazepines in panic disorder: A meta-analysis of common side effects in acute treatment.

Само регистрираните корисници можат да преведуваат статии

Пријавете се / пријавете се

Benzodiazepines (BZs) and selective serotonin reuptake inhibitors (SSRIs) are effective in the pharmacologic treatment of panic disorder (PD). However, treatment guidelines favor SSRIs over BZs based on the belief that BZs are associated with more adverse effects than SSRIs. This

Претходна
1
2
3
4
5
6
Следно

Придружете се на нашата
страница на Facebook

Herbal & Natural Medicine

Најкомплетната база на податоци за лековити билки поддржана од науката

Работи на 55 јазици
Лекови од билки поддржани од науката
Препознавање на билки по слика
Интерактивна GPS мапа - означете ги билките на локацијата (наскоро)
Прочитајте научни публикации поврзани со вашето пребарување
Пребарувајте лековити билки според нивните ефекти
Организирајте ги вашите интереси и останете во тек со истражувањето на новостите, клиничките испитувања и патентите

Напишете симптом или болест и прочитајте за билки што можат да помогнат, напишете билка и видете болести и симптоми против кои се користи.
* Сите информации се базираат на објавени научни истражувања